BIIB-021

BIIB-021 Basic information
Product Name:BIIB-021
Synonyms:CNF2024;9-[2-(2,2-diMethyl-propylaMino)ethyl]-8-(2-iodo-5-Methoxy-phenylsulfanyl)-9H-purin-6-ylaMine;CNF-2024EC102;9H-Purin-2-aMine, 6-chloro-9-[(4-Methoxy-3,5-diMethyl-2-pyridinyl)Methyl]-;6-chloro-9-((4-Methoxy-3,5-diMethylpyridin-2-yl)Methyl)-9H-purin-2-aMine;BIIB-021;BIIB021/CNF2024;6-Chloro-9-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]-9H-purin-2-amine
CAS:848695-25-0
MF:C14H15ClN6O
MW:318.76
EINECS:812-781-2
Product Categories:Aromatics;Heterocycles;Inhibitors;Intermediates & Fine Chemicals;Pharmaceuticals;Antineoplastic;Inhibitor
Mol File:848695-25-0.mol
BIIB-021 Structure
BIIB-021 Chemical Properties
Melting point 192-193℃
Boiling point 588.5±60.0 °C(Predicted)
density 1.50
storage temp. -20°C
solubility Soluble in DMSO (>25 mg/ml)
pka6.07±0.40(Predicted)
form solid
color White
Stability:Stable for 1 year as supplied. Solutions in DMSO may be stored at -20°C for up to 3 montha.
Safety Information
HS Code 2921490090
MSDS Information
BIIB-021 Usage And Synthesis
DescriptionBIIB021 is a potent HSP90 inhibitor (IC50 = 30 nM HER-2 degradation).1 It inhibited the proliferation of MCF7 and BT474 breast cancer cell lines (IC50 = 100 nM for each).? BIIB021 has shown efficacy as a therapeutic in multiple cancer models.2-5
UsesBIIB 021 an orally available, fully synthetic small-molecule inhibitor of the heat shock protein Hsp90. Studies show that BIIB 021 adminisitration led to degradation of Hsp90 client proteins measured in tumor tissue and resulted in the inhibition of tumor growth in several human tumor xenograft models.
DefinitionChEBI: A member of the class of 2-aminopurines that is 2-aminopurine which is substituted by a chlorine at position 6 and by a (4-methoxy-3,5-dimethylpyridin-2-yl)methyl group at position 9.
ReferencesKasibhatla et al. (2007), Rationally designed high-affinity 2-amino-6-halopurine heat shock protein 90 inhibitors that exhibit potent antitumor activity; J. Med. Chem. 50 2767 Lundgren et al. (2009), BIIB021, an orally available, fully synthetic small-molecule inhibitor of the heat shock protein Hsp90; Mol. Cancer Ther. 8 921 Boll et al. (2009), Heat shock protein 90 inhibitor BIIB021 (CNF2024) depletes NF-kappaB and sensitizes Hodgkin’s lymphoma cells for natural killer cell-mediated cytotoxicity; Clin. Cancer Res. 15 5108 Zhang et al. (2010), BIIB021, a synthetic Hsp90 inhibitor, has broad application against tumors with acquired multidrug resistance; Int. J. Cancer 126 1226 Wang et al. (2014), BIIB021, a novel Hsp90 inhibitor, sensitizes esophageal squamous cell carcinoma to radiation; Biochem. Biophys. Res. Commun. 452 945
BIIB-021 Preparation Products And Raw materials
Raw materials6-Chloroguanine-->2-Chloromethyl-4-methoxy-3,5-dimethylpyridine hydrochloride
Olaparib Ganetespib 17-AAG PD 0332991 HCl Imiquimod BI 2536 Onalespib AZ20 PU-H71 NOTUMib-1

Email:[email protected] [email protected]
Copyright © 2024 Mywellwork.com All rights reserved.